Casein-kinase-II-dependent phosphorylation of PPARγ provokes CRM1-mediated shuttling of PPARγ from the nucleus to the cytosol

Journal of Cell Science

Volumn 123, Issue 2, 2010, Pages 192-201

  von Knethen, Andreas ^a   Tzieply, Nico ^a   Jennewein, Carla ^a   Brüne, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Anti inflammation; Desensitization; Macrophages; Monocytes; Nuclear export

Indexed keywords

ALANINE; BINDING PROTEIN; CASEIN KINASE II; EXPORTIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RAN BINDING PROTEIN 3; RAN PROTEIN; SERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STRAIN HEK293; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; GENE MUTATION; HUMAN; HUMAN CELL; MOUSE; MUTANT; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CASEIN KINASE II; CELL NUCLEUS; CYTOSOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY ACIDS, UNSATURATED; GENE KNOCKDOWN TECHNIQUES; KARYOPHERINS; MICE; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; ORGANIC CHEMICALS; PHOSPHORYLATION; PPAR GAMMA; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RAN GTP-BINDING PROTEIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 73849127495     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.055475     Document Type: Article

References (29)

1. Akiyama, T. E., Sakai, S., Lambert, G., Nicol, C. J., Matsusue, K., Pimprale, S., Lee, Y. H., Ricote, M., Glass, C. K., Brewer, H. B., Jr and Gonzalez, F. J. (2002). Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol. Cell. Biol. 22, 2607-2609.
2. Askjaer, P., Bachi, A., Wilm, M., Bischoff, F. R., Weeks, D. L., Ogniewski, V., Ohno, M., Niehrs, C., Kjems, J., Mattaj, I. W. et al. (1999). RanGTP-regulated interactions of CRM1 with nucleoporins and a shuttling DEAD-box helicase. Mol. Cell. Biol. 19, 6276-6285.
3. Burgermeister, E., Chuderland, D., Hanoch, T., Meyer, M., Liscovitch, M. and Seger, R. (2007). Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma. Mol. Cell. Biol. 27, 803-817.
4. Daynes, R. A. and Jones, D. C. (2002). Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol. 2, 748-759.
5. Engelsma, D., Bernad, R., Calafat, J. and Fornerod, M. (2004). Supraphysiological nuclear export signals bind CRM1 independently of RanGTP and arrest at Nup358. EMBO J. 23, 3643-3652.
6. Gerry, J. M. and Pascual, G. (2008). Narrowing in on cardiovascular disease: the atheroprotective role of peroxisome proliferator-activated receptor gamma. Trends Cardiovasc. Med. 18, 39-44.
7. Gil, A., Andres-Pons, A., Fernandez, E., Valiente, M., Torres, J., Cervera, J. and Pulido, R. (2006). Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol. Biol. Cell 17, 4002-4013.
8. Glass, C. K. (2006). Going nuclear in metabolic and cardiovascular disease. J. Clin. Invest. 116, 556-560.
9. Hutten, S. and Kehlenbach, R. H. (2007). CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol. 17, 193-201.
10. Jennewein, C., Kuhn, A. M., Schmidt, M. V., Meilladec-Jullig, V., von Knethen, A., Gonzalez, F. J. and Brüne, B. (2008). Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines. J. Immunol. 181, 5646-5652.
11. Johann, A. M., von Knethen, A., Lindemann, D. and Brüne, B. (2006). Recognition of apoptotic cells by macrophages activates the peroxisome proliferator-activated receptor-gamma and attenuates the oxidative burst. Cell Death Differ. 13, 1533-1540.
12. Kelly, D., Campbell, J. I., King, T. P., Grant, G., Jansson, E. A., Coutts, A. G., Pettersson, S. and Conway, S. (2004). Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat. Immunol. 5, 104-112.
13. Kudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schreiner, E. P., Wolff, B., Yoshida, M. and Horinouchi, S. (1999). Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. USA 96, 9112-9117.
14. Kuhn, R., Schwenk, F., Aguet, M. and Rajewsky, K. (1995). Inducible gene targeting in mice. Science 269, 1427-1429.
15. Litchfield, D. W. (2003). Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem. J. 369, 1-15.
16. Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F. and Ahn, N. G. (1994). Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265, 966-970.
17. Mansour, S. J., Candia, J. M., Matsuura, J. E., Manning, M. C. and Ahn, N. G. (1996). Interdependent domains controlling the enzymatic activity of mitogen-activated protein kinase kinase 1. Biochemistry 35, 15529-15536.
18. Nelson, J. D., Denisenko, O. and Bomsztyk, K. (2006). Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1, 179-185.
19. O'Shea, J. J. and Murray, P. J. (2008). Cytokine signaling modules in inflammatory responses. Immunity 28, 477-487.
20. Panasyuk, G., Nemazanyy, I., Zhyvoloup, A., Bretner, M., Litchfield, D. W., Filonenko, V. and Gout, I. T. (2006). Nuclear export of S6K1 II is regulated by protein kinase CK2 phosphorylation at Ser-17. J. Biol. Chem. 281, 31188-31201.
21. Rigamonti, E., Chinetti-Gbaguidi, G. and Staels, B. (2008). Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men. Arterioscler. Thromb. Vasc. Biol. 28, 1050-1059.
22. Robinson, M. J., Stippec, S. A., Goldsmith, E., White, M. A. and Cobb, M. H. (1998). A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8, 1141-1150.
23. Straus, D. S. and Glass, C. K. (2007). Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol. 28, 551-558.
24. Tontonoz, P. and Spiegelman, B. M. (2008). Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 77, 289-312.
25. von Knethen, A., Soller, M., Tzieply, N., Weigert, A., Johann, A. M., Jennewein, C., Kohl, R. and Brune, B. (2007). PPARgamma1 attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes/ macrophages. J. Cell Biol. 176, 681-694.
26. Weigel, N. L. and Moore, N. L. (2007). Cyclins, cyclin dependent kinases, and regulation of steroid receptor action. Mol. Cell Endocrinol. 265-266, 157-161.
27. Xu, L. and Massague, J. (2004). Nucleocytoplasmic shuttling of signal transducers. Nat. Rev. Mol. Cell. Biol. 5, 209-219.
28. Yoon, S. O., Shin, S., Liu, Y., Ballif, B. A., Woo, M. S., Gygi, S. P. and Blenis, J. (2008). Ran-binding protein 3 phosphorylation links the Ras and PI3-kinase pathways to nucleocytoplasmic transport. Mol. Cell 29, 362-375.
29. Zingarelli, B. and Cook, J. A. (2005). Peroxisome proliferator-activated receptor-gamma is a new therapeutic target in sepsis and inflammation. Shock 23, 393-399.